EP0853486A3 - Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes - Google Patents
Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennesInfo
- Publication number
- EP0853486A3 EP0853486A3 EP96932773.3A EP96932773A EP0853486A3 EP 0853486 A3 EP0853486 A3 EP 0853486A3 EP 96932773 A EP96932773 A EP 96932773A EP 0853486 A3 EP0853486 A3 EP 0853486A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- viral
- aids
- cancer
- treatment
- therapeutic applications
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US428195P | 1995-09-25 | 1995-09-25 | |
US4281P | 1995-09-25 | ||
PCT/IB1996/001115 WO1997011667A2 (fr) | 1995-09-25 | 1996-09-25 | Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0853486A3 true EP0853486A3 (fr) | 1997-06-12 |
EP0853486A2 EP0853486A2 (fr) | 1998-07-22 |
EP0853486A4 EP0853486A4 (fr) | 2001-09-26 |
Family
ID=21710013
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96931214A Withdrawn EP0858327A2 (fr) | 1995-09-25 | 1996-09-25 | Utilisation de 2-mercaptoethanolamine (2-mea) et de composes aminothiols similaires, en combinaison avec du 3,5-diisopropyl-salicylate de cuivre (ii) et des composes similaires, pour le traitement et la prevention de differentes maladies |
EP96932773A Withdrawn EP0853486A4 (fr) | 1995-09-25 | 1996-09-25 | Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96931214A Withdrawn EP0858327A2 (fr) | 1995-09-25 | 1996-09-25 | Utilisation de 2-mercaptoethanolamine (2-mea) et de composes aminothiols similaires, en combinaison avec du 3,5-diisopropyl-salicylate de cuivre (ii) et des composes similaires, pour le traitement et la prevention de differentes maladies |
Country Status (5)
Country | Link |
---|---|
EP (2) | EP0858327A2 (fr) |
JP (1) | JPH11514990A (fr) |
AU (2) | AU6999096A (fr) |
CA (2) | CA2233445A1 (fr) |
WO (2) | WO1997011667A2 (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5994409A (en) | 1997-12-09 | 1999-11-30 | U.S. Bioscience, Inc. | Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds |
US6384259B1 (en) | 1998-11-16 | 2002-05-07 | Medimmune Oncology, Inc. | Stable amorphous amifostine compositions and dosage form |
US7939109B1 (en) * | 1999-10-04 | 2011-05-10 | John Carter | Method of treating neoplastic disease in a human or animal patient |
US7927612B2 (en) | 2000-01-19 | 2011-04-19 | Baofa Yu | Combinations and methods for treating neoplasms |
US6811788B2 (en) | 2000-01-19 | 2004-11-02 | Baofa Yu | Combinations and methods for treating neoplasms |
US6506413B1 (en) * | 2001-04-30 | 2003-01-14 | Joseph C. Ramaekers | Compositions for treating animal diseases and syndromes |
US7053072B2 (en) | 2001-05-11 | 2006-05-30 | Medimmune Oncology, Inc. | Methods for the administration of amifostine and related compounds |
FR2825923B1 (fr) * | 2001-06-15 | 2006-04-07 | Oreal | Inhibiteur de no-synthase et utilisations |
KR20030077743A (ko) * | 2002-03-26 | 2003-10-04 | 변현규 | In½ |
US7629333B2 (en) | 2002-03-29 | 2009-12-08 | Medimmune, Llc | Stable amorphous amifostine compositions and methods for the preparation and use of same |
AU2002353346A1 (en) * | 2002-09-10 | 2004-04-30 | Samir Chachoua | Induced remission therapy |
GB2398497A (en) * | 2003-02-19 | 2004-08-25 | Walcom Animal Science | Composition for improving immunity of animals |
US9125874B2 (en) | 2007-11-30 | 2015-09-08 | The Ramaekers Family Trust | Administration of transfer factor for improving reproductive health |
CN101138634A (zh) | 2006-09-07 | 2008-03-12 | 于保法 | 用于治疗肿瘤的组合物 |
EP2278984A4 (fr) | 2007-11-30 | 2013-02-27 | Ramaekers Family Trust | Compositions et procédés d'amélioration de la fertilité |
WO2010093606A1 (fr) * | 2009-02-11 | 2010-08-19 | Martin Heath Bluth | Echange réciproque sérum/plasma pour le traitement du cancer |
US11110303B2 (en) | 2014-11-26 | 2021-09-07 | Baofa Yu | Hapten-enhanced chemoimmunotherapy by ultra-minimum incision personalized intratumoral chemoimmunotherapy |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4228127A (en) * | 1978-10-06 | 1980-10-14 | International Radioimmune Systems, Inc. | Kit for detecting human chorionic gonadotropin |
US4952607A (en) * | 1982-05-27 | 1990-08-28 | International Copper Research Association, Inc. | Copper complex for treating cancer |
US5057314A (en) * | 1988-09-30 | 1991-10-15 | Whitfill Craig E | Low molecular weight antiviral factors |
US5310653A (en) * | 1989-10-24 | 1994-05-10 | Board Of Regents, The University Of Texas System | Tumor marker protein and antibodies thereto for cancer risk assessment or diagnosis |
US5488042A (en) * | 1992-03-13 | 1996-01-30 | Arch Development Corporation | Method for protection against genotoxic mutagenesis |
DE4236069A1 (de) * | 1992-10-26 | 1994-04-28 | Werner Dr Bergmann | Arzneimittel, insbesondere für orale Einnahme |
WO1994028934A1 (fr) * | 1993-06-07 | 1994-12-22 | Center For Special Immunology | Traitement adoptif de reconstitution immunitaire pour des patients atteints d'immunodeficiences acquises |
-
1996
- 1996-09-25 JP JP9513260A patent/JPH11514990A/ja not_active Ceased
- 1996-09-25 CA CA002233445A patent/CA2233445A1/fr not_active Abandoned
- 1996-09-25 EP EP96931214A patent/EP0858327A2/fr not_active Withdrawn
- 1996-09-25 AU AU69990/96A patent/AU6999096A/en not_active Abandoned
- 1996-09-25 AU AU71431/96A patent/AU7143196A/en not_active Abandoned
- 1996-09-25 WO PCT/IB1996/001115 patent/WO1997011667A2/fr not_active Application Discontinuation
- 1996-09-25 WO PCT/IB1996/001059 patent/WO1997011666A2/fr not_active Application Discontinuation
- 1996-09-25 CA CA002233015A patent/CA2233015A1/fr not_active Abandoned
- 1996-09-25 EP EP96932773A patent/EP0853486A4/fr not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0853486A3 (fr) | Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes | |
EP0853486A4 (fr) | Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes | |
AU3066992A (en) | Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids | |
AU2993297A (en) | Treatment of sickle cell disease, treatment of immune system diseases and other diseases normally associated with sickle cell anemia | |
EP0831873A4 (fr) | Therapie combinatoire pour le traitement d'infections virales vih et autres | |
PL319021A1 (en) | Body weight modulators, appropriate nucleic acid and proteins and their diagnostic and therapeutic application | |
EP2270046A3 (fr) | Procédés et compositions pour le traitement des maladies associées à hémolyse | |
AU2990695A (en) | Mucin-derived proteins for the diagnosis, imaging, and therapy of human cancer | |
AU5772296A (en) | 3,4-disubstituted-phenylsulphonamides and their therapeutic use | |
AU9312198A (en) | Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer | |
AU5772396A (en) | 3,4-disubstituted-phenylsulphonamides and their therapeutic use | |
AU7739396A (en) | Flow cytometric pharmacosensitivity assay and method of cancer treatment | |
AU6282896A (en) | Gene therapy of solid tumors with interferons alone or with other immuno-effector proteins | |
AU3092995A (en) | Breast specific genes and proteins | |
AU5847194A (en) | Novel entomopoxvirus genes, proteins and methods of use thereof | |
AUPQ344799A0 (en) | Treatment of respiratory diseases and infections | |
AU9269898A (en) | Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy | |
AU2796799A (en) | Amplification of gene transfer and gene therapy by controlled replication | |
CA2271478A1 (fr) | Expression specifique tissulaire de la proteine du retinoblastome | |
AU7529796A (en) | S-nitroso-hemoglobin and therapeutic uses thereof | |
AU8168898A (en) | Interferon stimulating protein and uses thereof | |
AU5369396A (en) | Rest protein and dna | |
AU3530395A (en) | Treatment of viral infections | |
AU6777596A (en) | Treatment of human prostate disease with beta-lapachone derivatives | |
GB9509461D0 (en) | DNA molecules and constructs and their use in the treatment of mastitis |